Skip to content
PubMed This is a summary of 111 peer-reviewed journal articles Updated
Cardiology

Mitral Valve Stenosis: A Patient Guide

At a Glance

Mitral valve stenosis narrows the valve that lets blood move through the left side of the heart. Medicines can relieve symptoms and reduce clot risk, but some people need a balloon procedure or surgery, followed by lifelong monitoring for recurrence.

Mitral valve stenosis is a mechanical condition where the heart’s “inlet” door—the valve between the upper and lower left chambers—becomes stiff, thickened, and narrowed. In a healthy heart, this door swings wide to allow oxygen-rich blood to fill the main pumping chamber, but in stenosis, the opening is restricted [1]. This creates a physical obstruction that forces the heart to work harder to push blood forward. While the narrowing typically develops slowly over many years, it eventually causes blood to back up into the lungs and the upper heart chamber, leading to symptoms like shortness of breath and fatigue [2].

Most cases of mitral stenosis stem from one of two distinct causes. Globally, the most common trigger is rheumatic fever, an inflammatory condition that may follow a childhood group A “strep” infection and cause the valve leaflets to fuse together decades later [1][3]. In older adults, the condition is more often caused by Mitral Annular Calcification (MAC), where mineral deposits build up in the ring supporting the valve, often in association with high blood pressure or kidney disease [4]. Regardless of the cause, the resulting narrowing acts as a bottleneck for your entire circulatory system, potentially leading to an irregular heart rhythm called atrial fibrillation or high pressure in the lung’s blood vessels [5][6].

Living with mitral stenosis requires an understanding that medications are supportive rather than curative. While pills like diuretics and heart-rate controllers can ease your symptoms, and anticoagulation protects against blood clots when indicated, they cannot dissolve the scar tissue or calcium blocking the valve [7][8]. Some patients are monitored indefinitely, but for appropriately selected patients, a physical intervention—either a balloon procedure to stretch the valve open or surgery to repair or replace it—is recommended [9][10]. For some, such as those planning a pregnancy, the “stress test” of increased blood volume makes addressing the valve before conception an essential safety measure [11][12].

Because the heart and its valves are dynamic, receiving a diagnosis is the start of a lifelong relationship with your cardiology team. Even after a successful procedure, the valve can sometimes begin to narrow again, a process known as restenosis [13]. This means that regular monitoring through echocardiograms remains a permanent part of your health routine to ensure your heart continues to function efficiently. By staying engaged with this surveillance, you can navigate the progression of the disease and time your treatments to maintain your quality of life [2][14]. Please do not start, stop, or change any heart medications without your treating clinician’s direct guidance.

Common questions in this guide

What usually causes mitral valve stenosis?
Worldwide, rheumatic fever after a group A strep infection is a common cause; it can scar and fuse the valve leaflets years later. In older adults, calcium buildup in the valve’s supporting ring, called mitral annular calcification, is another important cause and is associated with high blood pressure or kidney disease.
What symptoms can mitral valve stenosis cause?
A narrowed mitral valve can make blood back up toward the lungs, causing shortness of breath and fatigue. The condition can also contribute to an irregular rhythm called atrial fibrillation or increased pressure in the blood vessels of the lungs.
Can medicines open a narrowed mitral valve?
No. Diuretics and heart-rate medicines may ease symptoms, and anticoagulation may reduce clot risk when it is indicated, but these medicines do not remove scar tissue or calcium. Some people need a balloon procedure or surgery to repair or replace the valve.
How will my doctor know when mitral stenosis needs a procedure?
Your cardiology team considers your symptoms, imaging results, and the pressure in your heart and lungs. If the narrowing significantly limits blood flow or causes important symptoms, a balloon procedure or surgery may be recommended for an appropriately selected patient.
Will I need monitoring after treatment for mitral stenosis?
Yes. Regular follow-up and echocardiograms help track valve function and pressure because the valve can narrow again, a recurrence called restenosis, even after a successful procedure.
How can mitral stenosis affect pregnancy?
Pregnancy increases blood volume and can place extra stress on a narrowed mitral valve. If you are planning pregnancy, discuss the condition with your cardiology team; addressing the valve before conception may improve safety for some patients.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Based on my current symptoms and imaging, where do I stand in the progression of this condition?
  2. 2.Was my mitral stenosis likely caused by childhood rheumatic fever or age-related calcification (MAC)?
  3. 3.How does my heart valve condition affect my long-term plans, such as travel, exercise, or starting a family?
  4. 4.Is my current treatment plan focused on managing symptoms or preparing for a mechanical intervention?
  5. 5.How will we monitor the pressure in my heart and lungs to ensure we choose the right time for a procedure?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (14)
  1. 1

    Mechanisms of mitral valve development and disease.

    Wang E, Zhou B

    Frontiers in cardiovascular medicine 2026; (13()):1773671 doi:10.3389/fcvm.2026.1773671.

    PMID: 41717582
  2. 2

    Mitral Stenosis in the Multimodality Imaging Era: Pitfalls, Stress Echocardiography, and Integrated Therapeutic Assessment.

    Pala B, Piscione M, Gaudio D, et al.

    Diagnostics (Basel, Switzerland) 2026; (16(14)) doi:10.3390/diagnostics16142285.

    PMID: 42510148
  3. 3

    Prothymosin Alpha: A Novel Contributor to Estradiol Receptor Alpha-Mediated CD8+ T-Cell Pathogenic Responses and Recognition of Type 1 Collagen in Rheumatic Heart Valve Disease.

    Passos LSA, Jha PK, Becker-Greene D, et al.

    Circulation 2022; (145(7)):531-548 doi:10.1161/CIRCULATIONAHA.121.057301.

    PMID: 35157519
  4. 4

    Degenerative mitral valve stenosis: Diagnosis and management.

    Al-Taweel A, Almahmoud MF, Khairandish Y, Ahmad M

    Echocardiography (Mount Kisco, N.Y.) 2019; (36(10)):1901-1909 doi:10.1111/echo.14495.

    PMID: 31587368
  5. 5

    Management of atrial fibrillation in patients with rheumatic mitral stenosis.

    Iung B, Leenhardt A, Extramiana F

    Heart (British Cardiac Society) 2018; (104(13)):1062-1068 doi:10.1136/heartjnl-2017-311425.

    PMID: 29453328
  6. 6

    Pulmonary Hypertension in Aortic and Mitral Valve Disease.

    Maeder MT, Weber L, Buser M, et al.

    Frontiers in cardiovascular medicine 2018; (5()):40 doi:10.3389/fcvm.2018.00040.

    PMID: 29876357
  7. 7

    Rheumatic Mitral Valve Stenosis: Diagnosis and Treatment Options.

    Wunderlich NC, Dalvi B, Ho SY, et al.

    Current cardiology reports 2019; (21(3)):14 doi:10.1007/s11886-019-1099-7.

    PMID: 30815750
  8. 8

    Update on percutaneous mitral commissurotomy.

    Nunes MC, Nascimento BR, Lodi-Junqueira L, et al.

    Heart (British Cardiac Society) 2016; (102(7)):500-7 doi:10.1136/heartjnl-2015-308091.

    PMID: 26743926
  9. 9

    Advances in Rheumatic Mitral Stenosis: Echocardiographic, Pathophysiologic, and Hemodynamic Considerations.

    Silbiger JJ

    Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography 2021; (34(7)):709-722.e1 doi:10.1016/j.echo.2021.02.015.

    PMID: 33652082
  10. 10

    Echocardiography Assessment of Rheumatic Heart Disease: Implications for Percutaneous Balloon Mitral Valvuloplasty.

    Mohamed Ali A, Packer EJS, Omdal TR, et al.

    Current problems in cardiology 2023; (48(12)):102021 doi:10.1016/j.cpcardiol.2023.102021.

    PMID: 37544629
  11. 11

    Mitral Stenosis in Pregnancy: A Comprehensive Review of a Challenging Cardio-Obstetric Clinical Entity.

    Abdelrahman S, Yousif N

    Reviews on recent clinical trials 2019; (14(2)):136-140 doi:10.2174/1574887114666190207154413.

    PMID: 30734684
  12. 12

    Management of valvular disease in pregnancy: a global perspective.

    Sliwa K, Johnson MR, Zilla P, Roos-Hesselink JW

    European heart journal 2015; (36(18)):1078-89 doi:10.1093/eurheartj/ehv050.

    PMID: 25736252
  13. 13

    Independent Clinical and Echocardiographic Predictors of Restenosis After Percutaneous Mitral Balloon Commissurotomy in a Large, Consecutive Cohort Followed for 24 Years.

    Meneguz-Moreno RA, Ferreira-Neto AN, Gomes NL, et al.

    The Journal of invasive cardiology 2023; (35(3)):E113-E121 doi:10.25270/jic/22.00328.

    PMID: 36884359
  14. 14

    Analysis of Long-Term Effects of Percutaneous Balloon Mitral Valvotomy (PBMV) in 90 Patients With Rheumatic Mitral Stenosis: A Retrospective Analysis.

    Xu J, Liang N, Xiao Y, et al.

    Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 2026; (108(1)):124-129 doi:10.1002/ccd.70576.

    PMID: 42013245

This page is for informational purposes only and does not constitute medical advice about mitral valve stenosis. Your cardiology team should interpret your tests and guide medicines, procedures, pregnancy planning, and follow-up.

Get notified when new evidence is published on mitral valve stenosis.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.